Dr Nazia Chaudhuri is a respiratory physician with an expertise in interstitial lung disease (ILD) at Ulster University School of Medicine and Altnagelvin hospital, Western Health and social care trust, Londonderry, Northern Ireland. She has established and led the Northern Ireland Regional ILD Network and regional ILD multi-disciplinary meeting and was clinical lead of the ILD service at the Manchester University NHS Foundation Trust (MFT) from 2013-2022 and Deputy Clinical Director of the Respiraory service from 2019-2022. She is a senior clinical lecturer at the Ulster University School of Medicine as the Academic Medicine lead, Career and Employability lead and Specialised Foundation Programme lead  for the School of Medicine, Ulster University.

She graduated from the University of Leeds with an honours degree in Medicine and a BSc honours in Genetics. She performed a PhD and published her work looking at the cellular interactions and signalling pathways in response to infection and air pollution. She has publications and reviews related to her PhD work and continued with her research interests as an NIHR Clinical lecturer.

As an ILD specialist, Dr Chaudhuri developed and led the local Manchester ILD service by enhancing the delivery of care by establishing day case models to reduce waiting times, creating a clinical database and ensuring a presence on the internet by developing a website, twitter and Facebook page. She was instrumental in setting up and delivering a regional North West and Northern ILD network and has subsequently developed and led the Northern Ireland regional ILD network and MDT meetings.

Dr Chaudhuri has published her clinical experience in ILD and delivering MDT care and has presented many abstracts pertaining to IPF, antifibrotics and the importance of a multi-disciplinary team approach at all major respiratory conferences. She was chair of the British Thoracic Society (BTS) interstitial and rare lung disease registry (2023-2026), BTS ILD specialist advisory group (2020-2023) and a member of the BTS Research and Scientific committee (2020-2023). She is the secretary of the European Respiratory Society (ERS) Idiopathic Interstitial Pneumonia group (2025-current) and a council member (2023-Current) and the secretary of the Irish Thoracic Society (2026-Current). She was chair of the North West Thoracic Society from 2018-2022 and is the current secretary of the Ulster Thoracic Society (2025-Current). She is also a trustee of Pulmonary Fibrosis Northern Ireland and the Rare Disease Partnership Northern Ireland.

Dr Chaudhuri is actively involved in medical education and has a Postgraduate Certificate in Medical Education from Keele University and is a Senior Fellow of  the Higher Education Academy. She has many years experience in postgraduate education in her clinical supervisor roles.

As part of my PhD I looked at the role of cell signalling and networks in response to diesel exhaust and infections. I have published my work in peer reviewed journals.

My current interest is in interstitial lung disease (ILD),idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF).

I am principal investigator on a number of clinical research trials (>40 over 10 years) in idiopathic pulmonary fibrosis (IPF) and was the UK Chief Investigator of a major clinical trial on progressive ILDs and a trial in IPF. I am collaborator on a number of grants exceeding £5 million and have co-authored over 100 peer reviewed articles in 10 years. I was also co-applicant for a British Lung foundation grant for a study in Sarcoidosis.

I established a Respiratory Biobank for ILD Patients in Manchester NHS Trust.

I have Collaborated with Researchers at University of Manchester and Queens University Belfast in ILD and grant applications.

I have presented >50 abstracts at all Major Conferences in last 10 years and have published peer reviewed papers in my area of expertise

External PhD Examiner

Manchester University 2020

University of Sydney 2024.

RCSI 2026

Thesis committee Mariam Naqvi KCL 2026

PhD Co-supervisor

Volatile organic compounds in idiopathic pulmonary fibrosis

Dr Conal Hayton, University of Manchester

Reducing SSc-ILD Progression - Role of the pulmonary microenvironment. NICHS Apr 2025-Mar 2027.

Collaboration with Redzinc Services Ltd. Nov 24- Apr 25

Development of Imaging Biomarkers for the detection and monitoring of drug induced interstitial lung disease. 2017-2024.

Defining the relationship between Circadian disruption and interstitial lung disease AWARDED. Blaikley, J., Chaudhuri, N., Durrington, H. & Rutter, M. British Lung Foundation: £39,736.00. 1/01/21 → 1/01/24. Deadline: 12/10/20. Co-applicant

Defining the relationship between Circadian disruption and interstitial lung disease (OUTLINE) AWARDED. Blaikley, J., Chaudhuri, N., Durrington, H. & Rutter, M. British Lung Foundation: £39,285.00. 13/07/20 → 12/07/23. Co-applicant

The effect of circadian disruption/ sleep on IPF incidence and prognosis. Blaikley, J., Chaudhuri, N., Durrington, H. & Rutter, M. British Lung Foundation: £39,736.00. 1/03/21 → 29/02/24. Award date: 3/02/21. Co-applicant

Cough control therapy for Fibrotic Interstitial Lung Disease related chronic cough: feasibility study.  NIHR £237649. NIHR203571. Joint Lead Applicant

Treating idiopathic pulmonary fibrosis with the addition of lansoprazole. Award ID: NIHR12747 Award:£1,621,846.32 Start Date: September 2019 End Date: September 2023 Co-applicant

A parallel group, double-blind, randomised, placebo-controlled trial comparing the effectiveness and cost-consequence and cost effectiveness of low dose oral modified release morphine (MRM) versus placebo on the intensity of worst breathlessness in people with chronic breathlessness.Award ID: 17/34/01. Co-applicant. Award: £1,431,239.05. Start Date: March 2019. End Date: February 2024

BLF-SILA’ SARCOIDOSIS RESEARCH GRANT – 2017. Non-invasive profiling of breath volatile organic compounds in sarcoidosis: relation to the lung microbiome and markers of disease progression. Co-applicant. £119,962

 Innovation Medicine Initiative (IMI). Translational imaging methods in drug safety assessment (TRISTAN). Collaborative European award. PI

Boehringer Ingelheim Research Grant: Breath volatile analysis for biomarkers of response to therapy in Idiopathic Pulmonary Fibrosis.  A Pilot Study to Investigate Longitudinal Changes in Breath Biomarkers in Idiopathic Pulmonary Fibrosis. £248.116. Co-applicant 

Medical Lead Ulster University School of Medicine 2022- Current

Career and Employability Lead Ulster University School of Medicine 2024- Current.

Specialised Foundation Programme Lead Ulster University School of Medicine 2024- Current.

Academic advisor 2015-Current

Academic 3rd year lead for Manchester Medical School - April 2021-Nov 2022

I have completed a postgraduate certificate in Medical Education at Keele University in Sep 22

Senior Fellowship of the HIgher Education Academy 2024

POSTGRADUATES:

Specialised Foundation programme Clinical Supervisor 2025-Current

I have organised and delivered the CMT and FY1 foundation programme respiratory teaching. 2015-2022

I have organised and delivered speciaist training days on ILD. 2015-2022

I am an educational and clinical supervisor of many trainees. 2015-2022

I organise the only annual Interstitial Lung Disease Course in the UK. 2018-Current

I have spoken and presented at RCP Education Days on ILD (2019, 2020 2022) and ERS on many occasions 2018, 2021